Form 4: BioLife Solutions CMO Sells Shares to Cover Tax Obligations

BioLife Solutions Chief Marketing Officer, Todd Berard, sold 362 shares of common stock for $23.7 per share to satisfy tax withholding obligations related to restricted stock vesting.

Summary

• Todd Berard, Chief Marketing Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 362 shares of common stock.
• The shares were sold at a price of $23.7 per share.
• The sale was executed on June 10, 2025.
• Following this transaction, Mr. Berard beneficially owns 134,922 shares of common stock.
• The sale was conducted pursuant to a Rule 10b5-1(c) trading plan, which was adopted on March 8, 2024.
• The purpose of the sale was to satisfy tax withholding obligations in connection with the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, pre-planned sale for tax purposes, which typically does not reflect a change in management's outlook on the company's prospects.

Positives

• The sale was pre-planned under a Rule 10b5-1(c) trading plan, indicating a structured and non-discretionary transaction.
• The transaction's stated purpose is to satisfy tax withholding obligations, which is a common and routine reason for insider stock sales.

Negatives

• No inherently negative aspects are indicated by this routine, tax-related insider sale.

Future Outlook

The document, a Form 4, does not provide any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• Todd Berard stated that the sale was made pursuant to a Rule 10b5-1(c) trading plan adopted on March 8, 2024, to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Industry Context

This Form 4 filing reports a routine insider transaction, specifically a sale of shares by a company officer. Such transactions are common and often occur for personal financial planning or tax purposes, especially when executed under a Rule 10b5-1 plan, which allows insiders to set up pre-arranged trades to avoid accusations of trading on material non-public information. This filing does not provide information on broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The sale of 362 shares by a CMO is a very small percentage of the total shares outstanding and is unlikely to have a material impact on the company's share price or valuation. It is a routine transaction for tax purposes.

Key Dates

Keywords

BIOLIFE SOLUTIONS, BLFS, Form 4, Insider Trading, Stock Sale, Todd Berard, Chief Marketing Officer, 10b5-1 plan, Tax Withholding, Restricted Stock